What is Nick Hodge’s “Montel’s Miracle” Stock?

Checking out the medical device teased by Early Advantage

By Travis Johnson, Stock Gumshoe, September 2, 2014

Nick Hodge has been focusing a lot on biotech-ish companies for his Early Advantage newsletter lately, and they usually end up being pretty early-stage stocks with good stories about some kind of breakthrough or unique compound or device and no real financials yet (meaning, little to no revenue or earnings) — just the kind of thing that can can get an investor’s imagination fired up.

So the preliminary warning is this: I’m about to tell you about a company that has effectively no financials, a small pile of cash, and a story. What you want to do with that information is up to you, of course… but stocks that are this small and this bereft of financial data don’t trade on fundamentals, they trade on hope, imagination, and stories. And you can’t know when the enthusiasm about a story will rise or fall.

But you’re all grown-ups (no one under 18 would hav